AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Biopharmadive

Published November 11, 2026

AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning - BioPharma Dive

Read the full story at Biopharmadive

Elsewhere, a psychedelic depression drug was submitted to the FDA and an autoimmune disease-focused biotech's shares collapsed. Published Nov. 11,.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelic biotech